We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,146

National Development and Reform Council Issues Assesses Antitrust Penalty Against Medtronic
  • Watson & Band Law Offices
  • China
  • January 6 2017

On December 8th it was reported that the National Development and Reform Council (NDRC) issued an antitrust penalty against Medtronic, a world-famous


IP & IT Newsticker in CEESEE
  • Wolf Theiss
  • Albania, Austria, Bulgaria, China, Croatia, Czech Republic, Ukraine, European Union, Hungary, Poland, Serbia, Slovakia, Slovenia
  • December 14 2016

On 15 September 2016, the CJEU ruled in the Tobias McFadden case that a vendor offering an open free Wi-Fi network to the public cannot be held liable


Workplace health, safety, security & environment - Global Safety News
  • Clyde & Co LLP
  • Australia, China, Global, New Zealand
  • December 6 2016

Welcome to our inaugural edition of our quarterly global newsletter - Global Safety News - where we bring you interesting developments in HSE laws


International News: Focus on International Dispute Resolution
  • McDermott Will & Emery
  • Chile, China, European Union, France, USA
  • December 1 2016

In October 2016, the European Commission launched a public consultation to


Antitrust and Competition - The EU Weekly Briefing (10 October 2016)
  • Winston & Strawn LLP
  • China, Croatia, European Union, United Kingdom
  • October 10 2016

On 7 October 2016 the Commission made full use of the measures available in anti-dumping legislation (here and here), by imposing provisional


Expect the unexpected Patenting antibodies in Asia
  • FB Rice
  • China, Japan, South Korea
  • September 6 2016

Monoclonal antibodies are important human therapeutic agents and represent some of the largest selling drugs in the world. Patents relating to


Ramping up of antitrust enforcement in the Chinese pharmaceutical sector
  • Freshfields Bruckhaus Deringer LLP
  • China
  • August 23 2016

China's National Development and Reform Commission (NDRC), one of


China Newsletter, Summer 2016 No. 34
  • Greenberg Traurig LLP
  • China
  • August 10 2016

On March 23, 2016, the State Administration of Taxation (the Tax Bureau) and Ministry of Finance released the Notice of Overall Pilot Execution of


Pharmaceutical trademark protection in China
  • Kangxin Partners PC
  • China
  • July 11 2016

Author: Yu Li The rise in IP litigation involving pharmaceutical trademarks, generic drug names and commodity names suggests that rights holders


China: Trademark registration: a secret weapon
  • Kangxin Partners PC
  • China
  • July 1 2016

Unlike patents, registered trademarks benefit from 10 years of protection and unlimited renewals, making them a valuable tool when it comes to